Close

Anna Vassall

PhD

Professor
of Health Economics

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Tel.
++442079272141

Anna Vassall is a health economist with over twenty five years of experience in economic analysis and research in low and middle income countries. Prior to working for LSHTM, Anna worked for the UK's NHS supporting funding/contracting, DfID as a health economist in the UK/Pakistan and the Royal Tropical Institute, Amsterdam. She has extensive experience supporting national health planning and priority setting, aid effectiveness, and cost-effectiveness analysis in a wide range of low and middle income countries. She has directed and provided economic support to European Community and World Bank funded health sector reform and development projects in Yemen, East Timor, Syria and Sudan: supporting the development of health benefit package, national strategic plans and medium term expendtiure frameworks. Her PhD is in economic evaluation from the University of Amsterdam.

Anna is currently the Director of the Centre for Health Economics in London (CHiL) and sits in the Department of Global Health at LSHTM. She has worked at LSHTM since 2010 developing a research programme specialising on the economics of HIV services for key populations, sexual and reproductive health, gender based violence prevention and tuberculosis (TB). She has led a wide range of influential economic analyses on HIV prevention for key populations (Avahan programme), the integration and organisation of HIV care and treatment services (Integra project), and new diagnostics  for TB (Xpert MTB/RIF) and the prevention of violence against women and girls (What Works). She has an interest in methods to incorporate health systems and other constraints and a societal/equity focussed perspective into economic evaluation and priority setting. She is the module organiser for LSHTM's distance learning course in economic evaluation. 

She is a founding member of the TB-MAC modelling consortium and sits on the Strategic and Technical Advisory Group for the WHO's Global TB Programme (STAG-TB) and Task Force on Catastrophic Cost Measurement for TB, and recently sat on the Lancet Commission for TB. She is a lead investigator of the Global Health Costing Consortium; a Bill and Melinda Gates funded project to estimate and analyse HIV, TB and other health service costs globally. Anna is currently supporting several countries develop health benefit packages as part of the Disease Control Priorities (DCP) project. She was awarded the Joep Lange Chair at the Amsterdam Institute for Global Health, University of Amsterdam in 2018.

 

Affiliations

Department of Global Health and Development
Faculty of Public Health and Policy

Centres

TB Centre

Teaching

Anna is the module organiser for the economic evaluation distance learning course at LSHTM

Research

Anna's current research interests include: defining health benefit packages and priority setting; the economic evaluation of infectious disease interventions; costing global health interventions; and, the economics of the prevention of violence against woman and girls. She is developing methods for: the economic evaluation of intersectoral interventions; the inclusion of patient, community societal costs in economic evaluation; and, the economic evaluation of health systems interventions. She has a keen interest in 'real world' evaluation methods. She also continuees to publish on health financing, in particular the role of development assistance for health, and fiscal space analyses. 

Research Area
Complex interventions
Decision analysis
Diagnostics
Economic evaluation
Health care financing
Health systems
Health technology assessment
Infectious disease policy
Research : policy relationship
Sexual health
Equity
Global Health
Reproductive health
Modelling
Discipline
Development studies
Economics
Disease and Health Conditions
HIV/AIDS
Mental health
Tuberculosis
Non-communicable diseases
Sexually transmitted infection
Country
Bangladesh
Bolivia
Brazil
China
Egypt
Ethiopia
Georgia
Ghana
India
Kenya
Mozambique
Malawi
Nepal
Pakistan
Peru
Sudan
South Sudan
Swaziland
Timor-Leste
Tanzania
Uganda
Ukraine
Vietnam
Yemen
South Africa
Zambia
Region
Arab World
East Asia & Pacific (developing only)
Europe & Central Asia (developing only)
Least developed countries: UN classification
Middle East & North Africa (developing only)
Pacific island small states
South Asia
Sub-Saharan Africa (developing only)

Selected Publications

Costing guidelines for tuberculosis interventions
Cunnama L; Garcia Baena I; Gomez G; Laurence Y; Levin C; Siapka M; Sweeney S; Vassall A; Sinanovic E
2020
The impact of Coronavirus disease 2019 (COVID-19) on health systems and household resources in Africa and South Asia
Davies N; Sweeney S; Torres-Rueda S; Bozzani F; Kitson N; Barasa E; Procter S; Quaife M; Eggo R; Vassall A
2020
Tuberculosis infection prevention and control: why we need a whole systems approach.
Kielmann K; Karat AS; Zwama G; Colvin C; Swartz A; Voce AS; Yates TA; MacGregor H; McCreesh N; Kallon I
2020
Infectious diseases of poverty
Investing in the health of girls and women: a best buy for sustainable development.
Remme M; Vassall A; Fernando G; Bloom DE
2020
BMJ (Clinical research ed.)
Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa.
Sweeney S; Vassall A; Guinness L; Siapka M; Chimbindi N; Mudzengi D; Gomez GB
2020
PharmacoEconomics
What will it cost to prevent violence against women and girls in low- and middle-income countries? Evidence from Ghana, Kenya, Pakistan, Rwanda, South Africa and Zambia.
Torres-Rueda S; Ferrari G; Orangi S; Hitimana R; Daviaud E; Tawiah T; Prah RKD; Karmaliani R; Kapapa E; Barasa E
2020
Health policy and planning
Financing intersectoral action for health: a systematic review of co-financing models.
McGuire F; Vijayasingham L; Vassall A; Small R; Webb D; Guthrie T; Remme M
2019
Globalization and health
See more Publications